Obesity Surgery

, Volume 18, Issue 10, pp 1297–1304 | Cite as

Lipid Mobilization Following Roux-en-Y Gastric Bypass Examined by Magnetic Resonance Imaging and Spectroscopy

  • L. Johansson
  • M. Roos
  • J. Kullberg
  • J. Weis
  • H. Ahlström
  • M. Sundbom
  • B. Edén Engström
  • F. A. Karlsson
Research Article

Abstract

Background

Recent developments of magnetic resonance imaging (MRI) and spectroscopy have made it possible to quantify lipid deposited in different tissues. To what extent an improvement of glucose tolerance shortly after Roux-en-Y gastric bypass surgery (RYGBP) is reflected in lipid levels in liver and skeletal muscle, markers of insulin resistance, has not been clarified.

Methods

Whole-body MRI and MR spectroscopy (MRS) of liver and muscle and measurements of biochemical markers of glucose and lipid metabolism were performed at baseline and 1, 6, and 12 months following surgery in seven morbidly obese women. Volumes of adipose tissue depots and liver and muscle lipids were assessed from the MRI/MRS data.

Results

At 1 month postoperatively, body mass index and visceral and subcutaneous adipose tissues were reduced by 9%, 26%, and 10%, respectively, whereas no reductions in intrahepatocellular or skeletal intramyocellular lipid concentrations were found. Free fatty acid and beta-hydroxybutyrate levels were elevated two- and sixfold, respectively; glucose and insulin levels were lowered, indicating increased insulin sensitivity. Further weight loss up to 1 year was associated with reductions in all investigated lipid depots investigated, with the exception of the intramyocellular compartment.

Conclusion

RYGBP causes rapid lipid mobilization from visceral and subcutaneous adipose depots and enhanced free fatty acid flux to the liver. An exceptional disconnection between liver fat and insulin sensitivity occurs in the early dynamic phase after surgery. However, in the late phase, the energy restriction imposed by the surgical procedure also reduces the liver lipids, but not the intramyocellular lipids.

Keywords

Gastric bypass Hepatic lipids Free fatty acids Insulin Adiponectin Leptin 

Notes

Acknowledgements

We thank Margareta Ericson for expert technical assistance and Elisabeth Olsson for excellent care and samplings. This study was supported by Uppsala University, the Novo Nordisk Fund, and Ernfors Fund.

References

  1. 1.
    Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.PubMedCrossRefGoogle Scholar
  2. 2.
    Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15:474–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49:2136–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025–31.PubMedCrossRefGoogle Scholar
  5. 5.
    Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19:471–82.PubMedCrossRefGoogle Scholar
  7. 7.
    McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7–18.PubMedCrossRefGoogle Scholar
  8. 8.
    Nielsen S, Guo Z, Johnson CM, et al. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;113:1582–8.PubMedGoogle Scholar
  9. 9.
    Yki-Järvinen H, Westerbacka J. The fatty liver and insulin resistance. Curr Mol Med. 2005;5:287–95.PubMedCrossRefGoogle Scholar
  10. 10.
    Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr. 2002;22:325–46.PubMedCrossRefGoogle Scholar
  11. 11.
    Sinha R, Dufour S, Petersen KF, et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes. 2002;51:1022–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 2003;285:E906–16.PubMedGoogle Scholar
  13. 13.
    Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg. 2004;91:418–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Wildenhoff KE. A micro-method for the enzymatic determination of acetoacetate and 3-hydroxybutyrate in blood and urine. Scand J Clin Lab Invest. 1970;25:171–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Holdstock C, Edén Engström B, Öhrvall M, et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003;88:3177–83.PubMedCrossRefGoogle Scholar
  16. 16.
    Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Kullberg J, Angelhed JE, Lönn L, et al. Whole-body T1 mapping improves the definition of adipose tissue: consequences for automated image analysis. J Magn Reson Imaging. 2006;24:394–401.PubMedCrossRefGoogle Scholar
  18. 18.
    Naressi A, Couturier C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12:141–52.PubMedCrossRefGoogle Scholar
  19. 19.
    Weis J, Johansson L, Courivaud F, et al. Quantification of intramyocellular lipids in obese subjects using spectroscopic imaging with high spatial resolution. Magn Reson Med. 2007;57:22–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Lind L, Berne C, Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens. 1995;13:1457–62.PubMedGoogle Scholar
  21. 21.
    Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 2005;90:2804–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Westerbacka J, Cornér A, Tiikkainen M, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47:1360–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Yki-Järvinen H. Fat in the liver and insulin resistance. Ann Med. 2005;37:347–56.PubMedCrossRefGoogle Scholar
  24. 24.
    Sato F, Tamura Y, Watada H, et al. Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab. 2007;92:3326–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Larson-Meyer DE, Heilbronn LK, Redman LM, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006;29:1337–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Tiikkainen M, Bergholm R, Vehkavaara S, et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes. 2003;52:701–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Petersen KF, Dufour S, Befroy D, et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3:141–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Alvarado R, Alami RS, Hsu G, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005;15:1282–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Liu RC, Sabnis AA, Forsyth C, et al. The effects of acute preoperative weight loss on laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005;15:1396–402.PubMedCrossRefGoogle Scholar
  31. 31.
    Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg. 2004;14:1165–70.PubMedCrossRefGoogle Scholar
  32. 32.
    Lewis MC, Phillips ML, Slavotinek JP, et al. Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg. 2006;16:697–701.PubMedCrossRefGoogle Scholar
  33. 33.
    Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84:304–11.PubMedGoogle Scholar
  34. 34.
    Busetto L, Tregnaghi A, De Marchi F, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002;10:408–11.PubMedCrossRefGoogle Scholar
  35. 35.
    Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999;42:113–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Stannard SR, Thompson MW, Fairbairn K, et al. Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men. Am J Physiol Endocrinol Metab. 2002;283:E1185–91.PubMedGoogle Scholar
  37. 37.
    Johnson NA, Stannard SR, Rowlands DS, et al. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated. Diabet Med. 2006;23:1061–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51:144–51.PubMedCrossRefGoogle Scholar
  39. 39.
    Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91:1735–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • L. Johansson
    • 1
  • M. Roos
    • 2
  • J. Kullberg
    • 1
  • J. Weis
    • 1
  • H. Ahlström
    • 1
  • M. Sundbom
    • 3
  • B. Edén Engström
    • 2
  • F. A. Karlsson
    • 2
    • 4
  1. 1.Department of RadiologyUppsala University HospitalUppsalaSweden
  2. 2.Department of Medical SciencesUppsala University HospitalUppsalaSweden
  3. 3.Department of SurgeryUppsala University HospitalUppsalaSweden
  4. 4.Section of Endocrinology and Diabetes, Department of Medical SciencesUniversity HospitalUppsalaSweden

Personalised recommendations